The Promise of Quantitative Computed Tomography Coronary Angiography and Noninvasive Segmental Coronary Plaque Quantification Pushing the “Edge”⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. by Rumberger, John A.
ET
C
C
a
C
P
J
D
C
r
d
c
c
a
b
c
t
s
H
r
n
i
v
C
C
T
T
C
a
m
a
a
c
p
m
n
m
e
v
A
Journal of the American College of Cardiology Vol. 47, No. 3, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
Pp
Q
t
A
(
u
t
w
s
e
I
a
7
h
m
C
n
d
T
I
u
i
r
c
a
a
m
w
(
A
t
M
I
T
T
i
n
s
d
w
t
t
i
m
o
p
s
t
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.014DITORIAL COMMENT
he Promise of Quantitative
omputed Tomography
oronary Angiography
nd Noninvasive Segmental
oronary Plaque Quantification
ushing the “Edge”*
ohn A. Rumberger, PHD, MD, FACC
ublin, Ohio
ardiac computed tomography (CT) has undergone a
emarkable evolution in the past 25 years. In the past
ecade, we have seen further progress as first electron beam
omputed tomography (EBCT) and, later, multi-detector
omputed tomography (MDCT) were developed, validated,
nd applied to examine coronary atheromatous plaque.
See page 672
Quantification of coronary artery calcification (CAC)
y CT is now established as a valid “estimator” of total
oronary plaque burden, providing medium- and long-
erm cardiovascular prognostic information separate and
ignificantly incremental to conventional risk factors (1–3).
owever, although CAC is of confirmed clinical value in
isk stratification, 80% (or more) of coronary plaque is
oncalcified (4), and CAC provides only minimal insight
nto segmental stenosis severity (5), largely because of focal
ascular remodeling (6).
OMPUTED TOMOGRAPHY
ORONARY ANGIOGRAPHY (CTCA) AND
HE BEGINNING OF QUANTITATIVE COMPUTED
OMOGRAPHY CORONARY ANGIOGRAPHY (Q-CTCA)
ontrast-enhanced CTCA was developed in Germany (7)
nd the U.S. (8) in the mid-to-late 1990s as a noninvasive
ethod to estimate coronary luminal stenoses. It became
pparent that the administration of intravenous contrast
dditionally facilitated visualization of at least some noncal-
ified plaques adjacent to and separate from calcified mural
laque. These interesting observations led researchers to
use that CTCA might be a good candidate to pursue
oninvasive identification and quantification of focal plaque
orphology, that is, it might be possible to move from
stimations of global plaque volume and/or the absence/
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or thef
merican College of Cardiology.
From the Ohio State University, Dublin, Ohio.resence of obstructive stenoses toward true segmental
-CTCA.
There have been two previous investigations evaluating
he potential of CTCA to define focal coronary plaque.
chenbach et al. (9) compared intravascular ultrasound
IVUS) obtained during cardiac catheterization with CTCA
sing 16-slice MDCT. They found that CT had a sensi-
ivity of approximately 82% to detect coronary segments
ith any atherosclerotic plaque but that it had only a 53%
ensitivity to define segments with solely noncalcified ath-
rosclerotic plaque.
Leber et al. (10) also performed a comparison between
VUS and contrast-enhanced 16-slice MDCT. They reported
sensitivity for “soft” and/or fibrous plaque at approximately
8% while maintaining a sensitivity for “calcified” plaque (as
ad been shown in previous EBCT studies) of approxi-
ately 95%. Thus, in approximately 80% of the cases,
TCA was found to provide additional information about
oncalcified plaque, but total “atherosclerotic plaque bur-
en” remained significantly underdefined.
HE CURRENT STUDY
n this issue of the Journal, Leber et al. (11) extend their work
sing the latest 64-slice MDCT accompanied by further
mprovement in their analytic methods. Again, IVUS was the
eference standard. In their most recent study, they found
orrect detection of plaque in 83% of all atheromatous types
nd in 97% of “mixed”-type plaques but no change in the
ccuracy of defining calcified plaque (still 95%). Perhaps
ost impressively, the absence of any atheromatous plaque
as correctly ruled out by 64-slice MDCT in 192 of 204
94%) of the coronary segments defined as normal by IVUS.
dditionally, in the proximal coronary arteries, the correla-
ion of mean combined vessel plaque volume using 64-slice
DCT with direct mean combined vessel plaque volume by
VUS was significant (r  0.69).
HE EDGE
hese latest results are very encouraging. Basically, the data
mply that we have the potential to use CTCA, in a totally
oninvasive manner, to define/measure the “edges” that
eparate hard plaque from soft plaque and, furthermore,
istinguish these features from normal vessel wall. However,
hat do we need to do to move Q-CTCA even further into
he realm of clinical practicality? The answer to this ques-
ion lies in understanding the physics of, and then optimiz-
ng the approach to, cardiac “edge” detection with digital
ethods such as CT.
There are three important “edge” issues regarding the use
f CT to quantify hard “calcified” plaque, soft “noncalcified”
laque, coronary mural surfaces, and subsequent stenosis
everity: spatial resolution, low-contrast resolution, and
emporal resolution. All three figure prominently (but un-
ortunately not totally independently) in the process.
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February 7, 2006:678–80 Editorial CommentPATIAL RESOLUTION
hat might explain the considerable improvement from the
nitial Leber study published only a year ago and the current
tudy? One difference is that the newest 64-slice MDCT
canners have even better spatial (and to some extent
emporal) resolution than their 16-slice and EBCT prede-
essors. Acquiring CTCA in thinner slices now allows
mage reconstruction into “almost cubic” (isentropic) voxels
ignificantly facilitating three-dimensional calibrations and
easurements through an almost infinite number of imag-
ng planes.
The concept of quantifying the cardiac edge using CT
oes back to the initial cardiac CT studies performed by
niversity of Iowa researchers more than 20 years ago. The
esearch objective was quantifying left ventricular muscle
ass by EBCT. We devised a method to look at the
full-width half maximum” (FWHM) density between ven-
ricular boundaries as a continuum, appreciating that the
rue physical edge when rendered in image space was
alf-way between the CT densities of the true myocardium
nd the adjacent tissues. Once this was determined by direct
alculation, the consistency and subsequent accuracy to
ithin 5 g of ventricular muscle mass estimation by CT,
ompared with autopsy, was established (12,13).
Defining the “edge” for ventricular muscle, a large struc-
ure, compared with finding the edge of the much smaller
oronary artery is a fundamental issue of “resolution.”
eretofore much of the difficulty in resolving a small structure
uch as the coronary artery with CT had been due to unequal
imensions of the “pixel” (picture element) in the x-y plane
elated to the dimension defining slice depth in the z-plane;
hese characteristics define the three-dimensional “voxel”
volume element). Although the x-y spatial resolution of all
ardiac CT has remained in the sub-millimeter range for
ore than a decade, slice width or thickness was, until quite
ecently, significantly larger.
In a two-dimensional CT image, the border between two
hysically adjacent objects is composed of an array of pixels
hat render the image as a gradual array of finite gray scale
ensities separating the two objects; from a distance, these
bjects are distinct, but up close, the borders are actually a
lur. This transition zone between two adjacent objects in
he CT image and the transition “blur” between them is
artly a function of the size of the pixel in two dimensions
nd, more importantly, the size of the voxel in three
imensions. The true edge is distinct in physical space, but
n image space, there is a transition of finite dimension. The
oncept of FWHM defines this boundary as the CT density
alfway between the true reconstructed densities (gray scale
r Hounsfield units) of each of the separate objects sharing
common “edge.” The fidelity of the edge (i.e., the accuracy
f a measurement across the edge) becomes one of confi-
ence that is directly related to the pixel/voxel size (and
oronary motion blurring and low-density resolution). In
he current study by Leber et al. (11), they used a FWHM foncept to define the edges of various plaque elements but
etermined that the fidelity was somewhat in error—this is
ue, at least partly, to the spatial resolution of the CT data.
he current x-y-z voxel for the scanner used by Leber et al.
11) is roughly 0.4 mm 0.4 mm 0.6 mm and is still not
uite “cubic” but, more importantly, is still not nearly
ufficient for confident resolution of the structures in ques-
ion, where the minimal voxel dimensions (on each side)
hould be closer to that possible in the catheterization
aboratory, 0.1 mm or less.
OW-DENSITY RESOLUTION
asically, low-density resolution regards the fidelity of
eparating two objects of limited differential with respect to
T density. Although some of this ability may be overcome
y improved spatial resolution, in the world of CT, the
ifferences are highly dependent on the detector technology
sed. All of these detector materials (actually ceramics) have
short but finite “memory” after radiation exposure and this
efines the potential for afterglow. This is sort of like
omebody setting off a camera flash in your eyes; for a short
ime, the resolution of objects put in your line of site is
bscured. Improvements in detector technology will con-
inue to minimize this situation, but the detectors of the
lder 16-slice MDCT and the newer 64-slice MDCT are
asically, for the most part, the same.
EMPORAL RESOLUTION AND WHAT’S NEXT?
inally, we begin where it all began. Electron beam com-
uted tomography has been and continues to be the “fastest
f all CT” scanners, with scan speeds designed from
nception to image the beating heart (50 ms and 100 ms
omplete acquisition). It actually has significant low-
ontrast resolution because of its unique detector architec-
ure, but currently it lacks the necessary spatial resolution for
omplete plaque definition. Multidetector computed to-
ography has been adapted from general radiological ap-
lications that require high spatial resolution of static
bjects in which temporal resolution is not an issue. Rota-
ional speeds of MDCT have improved considerably and are
ow approaching 300 ms; however, this is still not ideal for
ll patients, and the current optimal clinical situation is to
ave heart rates of 60 to 65 beats/min or slower to minimize
oronary motion during acquisition. Although each CT
endor has methods to maximize temporal resolution using
nnovations such as partial scan reconstruction, these may
ompound other issues, producing additional artifacts after
rocessing. Optimal temporal resolution for cardiac CT
maging largely independent of normal heart rates remains a
ajor factor in making Q-CTCA a reality applicable across
arge numbers of individuals.
The goal is to make pixel/voxel image spatial/low-
ontrast resolution for cardiac CT smaller and better and, at
he same time, render negligible the additional confounding
actor of motion artifacts such that the confidence in and
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Editorial Comment February 7, 2006:678–80eproducibility of density measures for all coronary struc-
ures are maximized. How will this happen? It is not clear at
resent. One partial method might be to increase the power
f the scanner, but this then increases the radiation exposure
already at alarming values in some MDCT studies). An-
ther is to improve the detector technology. Interestingly,
he current four major CT vendors all use different materials
or their detectors, each with somewhat-different efficiencies
nd low-contrast resolution. The flat panel detector, now a
eature in some catheterization laboratories, has been dis-
ussed as part of the solution. It could significantly improve
he spatial resolution of CT, but current flat panel technol-
gy has issues of suboptimal low-contrast resolution due to
fterglow artifacts. Personally, I feel that the best approach
ould be to better develop the electron beam concept into a
ultisource (beam) product and then marry it with im-
roved multidetector ceramic technology, although this is
ot a trivial engineering challenge. However, incredible
dvances in MDCT technology have demonstrated that
ssues only conceived several years ago are now a clinical
eality.
HY THE FUSS?
n the early days of cardiac catheterization, the focus was on
he presence of “significant stenoses.” Later research showed
he potential for myocardial infarction was often greater in
omplex nonobstructive plaques (14), fostering concepts of
he vulnerable plaque/vulnerable patient that figure promi-
ently in current atherosclerosis research. Given the ever-
xpanding clinical applications for CTCA to define not only
oronary obstructive and nonobstructive disease on a segment-
y-segment basis but also chamber and congenital anatomy
nd function, the future is very exciting. Research has proven
AC as a valuable adjunct to defining cardiovascular
rognosis in the medium to long term, but we have lacked
reliable means to directly image the coronary arteries
oninvasively for prognosis in the short term. It will require
fundamental digital dissection of the plaque process
tself—a glimpse of which has been demonstrated in this
ssue of the Journal. This is a major innovation for the
linical definition of focal plaque characteristics and opens
p the potential for Q-CTCA as a research tool for lipid-
nd plaque-altering medications.
1eprint requests and correspondence: Dr. John A. Rumberger,
linical Professor of Medicine, The Ohio State University, Medical
irector, HealthWISE Wellness Diagnostic Center, 5747 Perime-
er Drive, Suite 105, Dublin, Ohio 43017. E-mail: jrumberger@
ealthwisecenter.com.
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